Tata Consultancy Services reported a 6% rise in net profit in the first quarter of FY26 but lower-than-expected revenue due to subdued discretionary spending and global uncertainties affecting demand.
JSW Infrastructure's Resolution Plan for NCR Rail Infrastructure Limited, owning a Private Freight Terminal in Khurja, Uttar Pradesh, has been approved by the Committee of Creditors, receiving a Letter of Intent on July 10.
Glenmark Pharmaceutical's subsidiary Ichnos Glenmark Innovation Inc signed a $700 million licensing deal with AbbVie for its lead drug candidate ISB 2001, showing promising outcomes in patients with relapsed / refractory multiple myeloma.
The developments involving HUL, TCS, JSW Infra, and Glenmark Pharma are expected to be significant in today’s trade due to the respective updates in their operations and partnerships.